Metabolomics in pneumonia and sepsis: an analysis of the GenIMS cohort study

Christopher Seymour, Sachin Yende, Melanie J. Scott, +10

Intensive Care Medicine

Genims Cohort StudyHealth SciencesMetabolomic ProfilingInflammatory MarkerSepsis +8

Retinal age gap as a predictive biomarker of future risk of Parkinson’s disease

Wenyi Hu, Wei Wang, Yueye Wang, +13

Age and Ageing

Retinal age gap as a predictive biomarker of stroke risk

Zhuoting Zhu, Wenyi Hu, Ruiye Chen, +14

BMC Medicine

The therapeutic effect of the BRD4-degrading PROTAC A1874 in human colon cancer cells

Ancheng Qin, Hua Jin, Yu Song, +5

Cell Death and Disease

A novel radioresistant mechanism of galectin-1 mediated by H-Ras-dependent pathways in cervical cancer cells

E-Y Huang, Yifan Chen, Yu‐Ming Chen, +5

Cell Death and Disease

Cell DeathPathologyGalectin-1 ExpressionTumor BiologyOncology +18

Tumor-associated macrophages expressing galectin-9 identify immunoevasive subtype muscle-invasive bladder cancer with poor prognosis but favorable adjuvant chemotherapeutic response

Yangyang Qi, Yuan Chang, Zewei Wang, +17

Cancer Immunology Immunotherapy

Tumor-associated MacrophagesTumor ImmunologyUrologyCancer ImmunosurveillanceGenitourinary Cancer +9

Alectinib (CH5424802) antagonizes ABCB1- and ABCG2-mediated multidrug resistance in vitro, in vivo and ex vivo

Ke Yang, Yifan Chen, Kenneth K.W. To, +4

Experimental & Molecular Medicine

Extracellular galectin-3 facilitates colon cancer cell migration and is related to the epidermal growth factor receptor.

Keng‐Liang Wu, Chung‐Mou Kuo, Eng‐Yen Huang, +5

PubMed

Cell SignalingImmunologyPathologyCancer Cell BiologyColorectal Cancer +13

Multiparametric MRI subregion radiomics for preoperative assessment of high-risk subregions in microsatellite instability of rectal cancer patients: a multicenter study

Zhiping Cai, Zhenyu Xu, Yifan Chen, +15

International Journal of Surgery

Amifostine alleviates radiation-induced lethal small bowel damage via promotion of 14-3-3σ-mediated nuclear p53 accumulation

Eng‐Yen Huang, Feng‐Sheng Wang, Yumin Chen, +5

Oncotarget